Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -53.34% is 46% above its 5-year average of -98.51%, near the high end of its 5-year range (-212.80%–-19.96%).
As of the fiscal period ended Tuesday, June 30, 2026. 20.51% below its 12-month average of -44.26%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -53.34%.
RETURN ON INVESTED CAPITAL (ROIC)
-53.34%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-44.26%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-57.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-98.51%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-98.99%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-98.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-96.63%
CURRENT VS TTM AVG
-20.51%
CURRENT VS 3Y AVG
+7.84%
CURRENT VS 5Y AVG
+45.85%
CURRENT VS 10Y AVG
+46.11%
CURRENT VS 15Y AVG
+45.72%
CURRENT VS 20Y AVG
+44.80%
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 660 covered companies
CURRENT VS SECTOR MEDIAN
-58.69%
vs the sector median at left
ABVC BioPharma, Inc.
Market Cap
$25.22M
Return on Invested Capital (ROIC)
-53.34%
TTM Avg
-44.26%
3Y Avg
-57.88%
5Y Avg
-98.51%
Market Cap
$25.57M
Return on Invested Capital (ROIC)
-59.10%
TTM Avg
-35.54%
3Y Avg
-33.20%
5Y Avg
-24.47%
Market Cap
$24.51M
Return on Invested Capital (ROIC)
-146.30%
TTM Avg
-66.51%
3Y Avg
-47.74%
5Y Avg
-43.26%
Market Cap
$24.09M
Return on Invested Capital (ROIC)
-78.16%
TTM Avg
-118.00%
3Y Avg
-120.55%
5Y Avg
-93.95%
Market Cap
$26.75M
Return on Invested Capital (ROIC)
-153.04%
TTM Avg
-84.65%
3Y Avg
-78.92%
5Y Avg
-71.84%
Market Cap
$27.55M
Return on Invested Capital (ROIC)
-103.04%
TTM Avg
-97.88%
3Y Avg
-84.76%
5Y Avg
-65.40%
Market Cap
$22.22M
Return on Invested Capital (ROIC)
-14.21%
TTM Avg
-12.54%
3Y Avg
-12.42%
5Y Avg
-37.50%
Market Cap
$28.49M
Return on Invested Capital (ROIC)
-109.29%
TTM Avg
-89.70%
3Y Avg
-72.19%
5Y Avg
-61.37%
Market Cap
$21.77M
Return on Invested Capital (ROIC)
-248.21%
TTM Avg
-225.06%
3Y Avg
-147.38%
5Y Avg
-102.77%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ABVC BioPharma, Inc. (ABVC) | $25.22M | -53.34% | -44.26% | -57.88% | -98.51% |
| iTonic Holdings Ltd. (ITOC)vs › | $25.57M | -59.10% | -35.54% | -33.20% | -24.47% |
| Atossa Therapeutics, Inc. (ATOS)vs › | $24.51M | -146.30% | -66.51% | -47.74% | -43.26% |
| Kyntra Bio, Inc. (KYNB)vs › | $24.09M | -78.16% | -118.00% | -120.55% | -93.95% |
| InspireMD, Inc. (NSPR)vs › | $26.75M | -153.04% | -84.65% | -78.92% | -71.84% |
| Seres Therapeutics, Inc. (MCRB)vs › | $27.55M | -103.04% | -97.88% | -84.76% | -65.40% |
| Aytu BioPharma, Inc. (AYTU)vs › | $22.22M | -14.21% | -12.54% | -12.42% | -37.50% |
| aTyr Pharma, Inc. (ATYR)vs › | $28.49M | -109.29% | -89.70% | -72.19% | -61.37% |
| LeonaBio, Inc. (LONA)vs › | $21.77M | -248.21% | -225.06% | -147.38% | -102.77% |
| Modular Medical, Inc. (MODD)vs › | $21.03M | -253.57% | -160.85% | -171.27% | -226.34% |
ROIC
-53.3%
ROE
-76.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -53.34% |
| 2026-03-31 | -56.73% |
| 2025-12-31 | -47.39% |
| 2025-09-30 | -33.26% |
| 2025-06-30 | -30.60% |
| 2025-03-31 | -19.96% |
| 2024-12-31 | -109.76% |
| 2024-09-30 | -55.46% |
| 2024-06-30 | -73.77% |
| 2024-03-31 | -87.57% |
| 2023-12-31 | -203.19% |
| 2023-09-30 | -68.87% |
| 2023-06-30 | -163.35% |
| 2023-03-31 | -148.79% |
| 2022-12-31 | -188.61% |
| 2022-09-30 | -212.80% |
| 2022-06-30 | -116.43% |
| 2022-03-31 | -129.85% |
| 2021-12-31 | -98.59% |
| 2021-09-30 | -73.92% |
| 2021-06-30 | -96.48% |
| 2021-03-31 | -76.27% |
| 2020-12-31 | -67.44% |
| 2020-09-30 | -140.63% |
| 2020-06-30 | -65.54% |
| 2020-03-31 | -105.07% |
| 2019-12-31 | -76.65% |
| 2019-09-30 | -76.60% |
| 2016-09-30 | -14517.38% |
| 2016-06-30 | -193.78% |
| 2016-03-31 | -763.09% |
| 2015-12-31 | -56.28% |
| 2015-09-30 | -94.91% |
| 2013-06-30 | -122.97% |
| 2007-09-30 | -795.88% |
| 2007-06-30 | -96.17% |
| 2007-03-31 | -5859.29% |
| 2006-12-31 | -3962.19% |
| 2006-09-30 | -3113.42% |
| 2006-06-30 | -44.30% |
| 2006-03-31 | -31.68% |
| 2005-12-31 | -25.96% |
| 2005-09-30 | -36.08% |
| 2005-06-30 | 3.74% |
| 2005-03-31 | -0.55% |
| 2004-12-31 | 2.30% |
| 2004-09-30 | -1.48% |
| 2004-06-30 | -57.93% |
